MassBiologics

Boston, MA
Find alternatives to MassBiologics for AAV →
Program data pending ClinicalTrials.gov matching · Last scored 2026-10-29
78.8
Signal Score
✓ FDA Inspections (2) ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: MassBiologics

Signal Score
78.8/100 (as of 2026-10-29)
Quality Compliance
96.8/100
Headquarters
Boston, MA
Modalities
AAV, mRNA
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About MassBiologics

Pure-play CDMO.

Signal Score & Pillar Breakdown

Quality Compliance 96.8
FDA Inspections2 on record
Warning Letters0
Last InspectionVoluntary Action Indicated (VAI) (2025-12-18)
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesAAV, mRNA
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability 68.0
Parent company: UMass Chan Medical School
Financial assessment: 68.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: UMass Chan Medical School
Financial assessment: 68.0/100
Capacity 58.0
1 manufacturing site: Boston, MA
Modalities: AAV, mRNA
Capacity assessment: 58.0/100
Sites: Boston, MA
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
1 manufacturing site: Boston, MA
Modalities: AAV, mRNA
Capacity assessment: 58.0/100

MassBiologics FDA Inspection History

2025-12
2022-09
NAI VAI OAI
Date Site Type 483 citations posted Classification
2025-12-18
MassBiologics
Boston, Massachusetts Facility-linked
Human Cellular, Tissue, and Gene Therapies Yes Voluntary Action Indicated (VAI)
2022-09-01
MassBiologics
Boston, Massachusetts Facility-linked
Vaccines and Allergenic Products Not posted Voluntary Action Indicated (VAI)
Source: FDA Data Dashboard · Retrieved Nov 21, 2026

MassBiologics FDA 483 Findings 1 observations · 2025-12-18 → 2025-12-18 ?

By subsystem

  • CAPA 1 (100.0%)

By severity

  • 3 — Moderate: 1
  • Repeat observations: 0

Most severe findings

  • Moderate (3) CAPA 2025-12-18 21 CFR 211.180(e)(2)
    Items to cover on annual reviews

    "Written procedures are not established for evaluations done at least annually and including provisions for a review of complaints, recalls, returned or salvaged drug products and investigations conducted for each drug product."

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data. This company's careers site asks automated readers not to collect it (robots.txt), and we respect that.
Source: public careers pages · Checked Nov 20, 2026

Frequently Asked Questions About MassBiologics

How many FDA inspections does MassBiologics have on record?
CDMO Signal tracks 2 FDA inspections for MassBiologics, sourced from the FDA inspection database. See the full inspection history above.
Has MassBiologics received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for MassBiologics.
What is MassBiologics's CDMO Signal Score?
MassBiologics has a Signal Score of 79/100, based on quality, operations, financial stability, and capacity data.
Evaluating MassBiologics for a manufacturing program?
Use the free AI matchmaker to compare MassBiologics against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
AAV CDMOs → mRNA CDMOs →

Similar CDMOs

Cytiva (Mfg Services)
Marlborough, MA · Uppsala, SE
Signal Score: 65.5
Cell Therapy, AAV, mRNA
FUJIFILM Diosynth Biotechnologies
Research Triangle, NC · Holly Springs, NC · Hillerod, DK
Signal Score: 86.7
AAV, mRNA/LNP, Biologics, mRNA, Microbial Fermentation, Recombinant Protein
ReciBioPharm
Keele, UK · Sodertalje, SE
Signal Score: 82.9
AAV, Lentiviral, Plasmid, mRNA
Catalent
Tampa, FL
Signal Score: 76.1
Monoclonal Antibody, Recombinant Protein, ADC, AAV, mRNA, Plasmid DNA, Fill-Finish
Danaher (CGT Portfolio)
Washington, DC
Signal Score: 73.0
Cell Therapy, AAV, mRNA

Compare MassBiologics with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on MassBiologics
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.